- “Thousands of lives lost”? Why calls for faster drug approvals need more scrutiny
- Deregulating the FDA: Back to thalidomide?
- Providing Light on the Sunshine Act
- How fast to “cures” and at what cost? Politico forum tilts toward pharma-friendly messaging
- The 21st Century Cures Act: More Homework To Do
- Regulating Antibiotics in an Era of Resistance: The Historical Basis and
Continued Need for Adequate and Well-Controlled Investigations - “Potential biomarker that could predict”? – caveats about psychiatric brain imaging & blogging about it
- NPA FDA Task Force Testimony Before the Anti-Infective Drug Advisory Committee
- FDA Draft Guidance on the Distribution of Risk Information by Pharmaceutical Companies Falls Short of Ensuring Patient Safety
- Putting Patients First In Congress: A Lobbying Experience
- Antibiotics to patients: too much, too often
- FDA-Approved: Protecting the Legacy of Heroes
